MoneyWorks4Me

Innova Captab - Quaterly Results

07 Aug 2025 Evaluate
The Sales for the quarter ended June 2025 of Rs. 2869.79 millions rose by 26.52% from Rs. 2268.32 millions.The Net proft of the company remain more or less same to Rs. 202.95  millions from Rs. 223.36 millions ,decline by -9.14%.OP of the company witnessed a marginal growth to 391.36 millions from 330.89 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 2869.79 2268.32 26.52 2869.79 2268.32 26.52 9580.61 8649.29 10.77
Other Income 43.15 46.43 -7.06 43.15 46.43 -7.06 167.75 107.18 56.51
PBIDT 391.36 330.89 18.27 391.36 330.89 18.27 1390.74 1186.88 17.18
Interest 27.68 0.89 3010.11 27.68 0.89 3010.11 21.68 135.91 -84.05
PBDT 363.68 330.00 10.21 363.68 330.00 10.21 1369.06 1050.97 30.27
Depreciation 90.76 30.55 197.09 90.76 30.55 197.09 170.15 113.99 49.27
PBT 272.92 299.45 -8.86 272.92 299.45 -8.86 1198.91 936.98 27.95
TAX 69.97 76.09 -8.04 69.97 76.09 -8.04 304.21 255.37 19.13
Deferred Tax 18.75 28.85 -35.01 18.75 28.85 -35.01 84.21 3.53 2285.55
PAT 202.95 223.36 -9.14 202.95 223.36 -9.14 894.70 681.61 31.26
Equity 572.25 572.25 0.00 572.25 572.25 0.00 572.25 572.25 0.00
PBIDTM(%) 13.64 14.59 -6.51 13.64 14.59 -6.51 14.52 13.72 5.79
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..